(Q44061427)

29 November 2017

title

4-Aminoarylguanidine and 4-aminobenzamidine derivatives as potent and selective urokinase-type plasminogen activator inhibitors (English)

1 reference

29 November 2017

8

Richard L Mackman

1 reference

29 November 2017

Jeffrey R Spencer

1

1 reference

29 November 2017

Danny McGee

2

1 reference

29 November 2017

Darin Allen

3

1 reference

29 November 2017

Bradley A Katz

4

1 reference

29 November 2017

Christine Luong

5

1 reference

29 November 2017

Martin Sendzik

6

1 reference

29 November 2017

Neil Squires

7

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

Bioorganic & Medicinal Chemistry Letters

29 November 2017

published in

1 reference

29 November 2017

volume

12

1 reference

29 November 2017

issue

15

1 reference

29 November 2017

page(s)

2023-2026

1 reference

The urokinase-type plasminogen activator system in cancer metastasis: a review

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900312-8

7 January 2021

Prevention of prostate-cancer metastasis in vivo by a novel synthetic inhibitor of urokinase-type plasminogen activator (uPA).

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900312-8

7 January 2021

Maximum effect of urokinase plasminogen activator inhibitors in the control of invasion and metastasis of rat mammary cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900312-8

7 January 2021

Development of serine protease inhibitors displaying a multicentered short (<2.3 A) hydrogen bond binding mode: inhibitors of urokinase-type plasminogen activator and factor Xa.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900312-8

7 January 2021

A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900312-8

7 January 2021

Engineering inhibitors highly selective for the S1 sites of Ser190 trypsin-like serine protease drug targets

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900312-8

7 January 2021

Exploiting subsite S1 of trypsin-like serine proteases for selectivity: potent and selective inhibitors of urokinase-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900312-8

7 January 2021

(4-aminomethyl)phenylguanidine derivatives as nonpeptidic highly selective inhibitors of human urokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900312-8

7 January 2021

Selective inhibition of urokinase by substituted phenylguanidines: quantitative structure-activity relationship analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900312-8

7 January 2021

10.1016/S0960-894X(02)00312-8

Identifiers

DOI

1 reference

29 November 2017

1 reference